AbCellera Biologics Inc. ( ABCL) - Key Metrics
ABCL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.15 | -$0.03 | -$0.12 | -$0.15 |
| 2025Q3 | $0.03 | -$0.19 | -$0.18 | -$0.21 |
| 2025Q2 | $0.06 | -$0.12 | -$0.11 | -$0.15 |
| 2025Q1 | $0.01 | -$0.15 | -$0.04 | -$0.07 |
ABCL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -28.55 |
| 2025Q3 | ? | -6.58 |
| 2025Q2 | ? | -7.37 |
| 2025Q1 | ? | -3.64 |
ABCL
Price: $5.72
52 week price:
Earnings Per Share: -0.48 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 1.3 million
Market Capitalization: 1.2 billion